Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: LT who wrote (1339)	6/18/1998 10:14:00 PM
From: Jim B	Read Replies (1) \| Respond to of 5402

that is true.. "FUNDS" do not invest in penny stocks... any institution or company can buy into OTC stocks if they go through the properly channels deemed by their company or board of directors or whatever.. for instance go check out CITN... MMWW CORESTAFF has been buying up lots of their shares.. I've followed them for 3 months now and even met with the company .. it is documented with EDGAR that institutions have been buying their stock... anyway, it is done... nothing I know of that says a company has to be listed on a big board before a company can buy them out or simply buy some shares... don't kid yourselves people... large corporations are looking at this one as we speak... is this fact... probably... can I prove it.. NOPE... so yeah yeah.. more hype... well, BATTELLE is here.. and they are just the beginnig.. imho.. good night all! jim

To: LT who wrote (1339)	6/18/1998 10:17:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

LT Watch and Learn!!!! Prospector

To: LT who wrote (1339)	6/18/1998 10:33:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 5402

LT, is is true that funds will not generally invest in OTCBB stocks and some are prohibited by their by laws from doing so. However, as with anything human, there are, of course exceptions. Furthermore the term being used here is "institutional buying," which covers a lot more than mutual funds--banks, investment groups, retirement funds, etc., etc. Certainly you wouldn't find a Fidelity fund taking a position in SGNC, but some more speculative groups might possibly be interested. And with the small market cap and relatively small float, even a little institutional buying could make a difference. There is a great need for a viable blood substitute and there has not been great luck in producing one. The winner(s) will make a fortune. But the odds are long.